Trial Profile
A non-interventional, observational study to evaluate the Propiverine and its effects of flexible dosing in 1335 Patients with overactive bladder.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2015
Price :
$35
*
At a glance
- Drugs Propiverine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 18 Dec 2015 New trial record